Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma

In this research, we investigated the role of PIK3R6, a regulatory subunit of PI3Kγ, known for its tumor-promoting properties, in clear cell renal cell carcinoma (CCRCC). Utilizing the UALCAN website, we found PIK3R6 upregulated in CCRCC, correlating with lower survival rates. We compared PIK3R6 exp...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia Yang, Xiaoni Zhong, Xiaoling Gao, Wenyi Xie, Yaokai Chen, Yuanjiang Liao, Peilin Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Cell Adhesion & Migration
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19336918.2024.2353920
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850129056354271232
author Jia Yang
Xiaoni Zhong
Xiaoling Gao
Wenyi Xie
Yaokai Chen
Yuanjiang Liao
Peilin Zhang
author_facet Jia Yang
Xiaoni Zhong
Xiaoling Gao
Wenyi Xie
Yaokai Chen
Yuanjiang Liao
Peilin Zhang
author_sort Jia Yang
collection DOAJ
description In this research, we investigated the role of PIK3R6, a regulatory subunit of PI3Kγ, known for its tumor-promoting properties, in clear cell renal cell carcinoma (CCRCC). Utilizing the UALCAN website, we found PIK3R6 upregulated in CCRCC, correlating with lower survival rates. We compared PIK3R6 expression in CCRCC tumor tissues and adjacent normal tissues using immunohistochemistry. Post RNA interference-induced knockdown of PIK3R6 in 786-O and ACHN cell lines, we performed CCK-8, colony formation, Edu staining, flow cytometry, wound healing, and transwell assays. Results showed that PIK3R6 silencing reduced cell proliferation, migration, and invasion, and induced G0/G1 phase arrest and apoptosis. Molecular analysis revealed decreased CDK4, Cyclin D1, N-cadherin, Vimentin, Bcl-2, p-PI3K and p-AKT, with increased cleaved caspase-3, Bax, and E-cadherin levels in CCRCC cells. Moreover, inhibiting PIK3R6 hindered tumor growth. These findings suggest a significant role for PIK3R6 in CCRCC cell proliferation and metastasis, presenting it as a potential therapeutic target.
format Article
id doaj-art-284ac985eee94b929a62c80fd646c616
institution OA Journals
issn 1933-6918
1933-6926
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Cell Adhesion & Migration
spelling doaj-art-284ac985eee94b929a62c80fd646c6162025-08-20T02:33:07ZengTaylor & Francis GroupCell Adhesion & Migration1933-69181933-69262024-12-0118111210.1080/19336918.2024.2353920Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinomaJia Yang0Xiaoni Zhong1Xiaoling Gao2Wenyi Xie3Yaokai Chen4Yuanjiang Liao5Peilin Zhang6College of Public Health, Chongqing Medical University, Chongqing, ChinaCollege of Public Health, Chongqing Medical University, Chongqing, ChinaDepartment of Nephrology, Chongqing Ninth People’s Hospital, Chongqing, ChinaDepartment of Nephrology, Chongqing Ninth People’s Hospital, Chongqing, ChinaScientific Research and Education Department, Chongqing Public Health Medical Center, Chongqing, ChinaDepartment of Nephrology, Chongqing Ninth People’s Hospital, Chongqing, ChinaCost Management Research Center, Chongqing Ninth People’s Hospital, Chongqing, ChinaIn this research, we investigated the role of PIK3R6, a regulatory subunit of PI3Kγ, known for its tumor-promoting properties, in clear cell renal cell carcinoma (CCRCC). Utilizing the UALCAN website, we found PIK3R6 upregulated in CCRCC, correlating with lower survival rates. We compared PIK3R6 expression in CCRCC tumor tissues and adjacent normal tissues using immunohistochemistry. Post RNA interference-induced knockdown of PIK3R6 in 786-O and ACHN cell lines, we performed CCK-8, colony formation, Edu staining, flow cytometry, wound healing, and transwell assays. Results showed that PIK3R6 silencing reduced cell proliferation, migration, and invasion, and induced G0/G1 phase arrest and apoptosis. Molecular analysis revealed decreased CDK4, Cyclin D1, N-cadherin, Vimentin, Bcl-2, p-PI3K and p-AKT, with increased cleaved caspase-3, Bax, and E-cadherin levels in CCRCC cells. Moreover, inhibiting PIK3R6 hindered tumor growth. These findings suggest a significant role for PIK3R6 in CCRCC cell proliferation and metastasis, presenting it as a potential therapeutic target.https://www.tandfonline.com/doi/10.1080/19336918.2024.2353920MigrationPIK3R6proliferationrenal cell carcinomatumor growth
spellingShingle Jia Yang
Xiaoni Zhong
Xiaoling Gao
Wenyi Xie
Yaokai Chen
Yuanjiang Liao
Peilin Zhang
Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma
Cell Adhesion & Migration
Migration
PIK3R6
proliferation
renal cell carcinoma
tumor growth
title Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma
title_full Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma
title_fullStr Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma
title_full_unstemmed Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma
title_short Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma
title_sort knockdown of pik3r6 impedes the onset and advancement of clear cell renal cell carcinoma
topic Migration
PIK3R6
proliferation
renal cell carcinoma
tumor growth
url https://www.tandfonline.com/doi/10.1080/19336918.2024.2353920
work_keys_str_mv AT jiayang knockdownofpik3r6impedestheonsetandadvancementofclearcellrenalcellcarcinoma
AT xiaonizhong knockdownofpik3r6impedestheonsetandadvancementofclearcellrenalcellcarcinoma
AT xiaolinggao knockdownofpik3r6impedestheonsetandadvancementofclearcellrenalcellcarcinoma
AT wenyixie knockdownofpik3r6impedestheonsetandadvancementofclearcellrenalcellcarcinoma
AT yaokaichen knockdownofpik3r6impedestheonsetandadvancementofclearcellrenalcellcarcinoma
AT yuanjiangliao knockdownofpik3r6impedestheonsetandadvancementofclearcellrenalcellcarcinoma
AT peilinzhang knockdownofpik3r6impedestheonsetandadvancementofclearcellrenalcellcarcinoma